Lina Yang

2.9k total citations
113 papers, 2.2k citations indexed

About

Lina Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lina Yang has authored 113 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 26 papers in Cancer Research and 22 papers in Oncology. Recurrent topics in Lina Yang's work include Remote-Sensing Image Classification (15 papers), Remote Sensing and Land Use (13 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Lina Yang is often cited by papers focused on Remote-Sensing Image Classification (15 papers), Remote Sensing and Land Use (13 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Lina Yang collaborates with scholars based in China, United States and Japan. Lina Yang's co-authors include Gong Yang, Lianru Gao, Bing Zhang, Xu Sun, Xun Sun, Sheng‐ce Tao, Ziliang Wang, Jingshu Wang, Tianhe Chi and Fan Liang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Lina Yang

104 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lina Yang China 25 1.0k 533 383 302 163 113 2.2k
Anqi Lin China 28 782 0.7× 1.1k 2.0× 381 1.0× 522 1.7× 630 3.9× 146 2.5k
Baohua Zhang China 33 750 0.7× 318 0.6× 457 1.2× 93 0.3× 237 1.5× 146 3.1k
Zhuowei Hu China 30 1.0k 1.0× 314 0.6× 338 0.9× 530 1.8× 589 3.6× 97 3.0k
Junjie Zhu China 20 936 0.9× 205 0.4× 258 0.7× 146 0.5× 206 1.3× 78 1.8k
Kai Song China 23 614 0.6× 272 0.5× 162 0.4× 253 0.8× 133 0.8× 64 1.5k
Noriaki Hashimoto Japan 23 575 0.6× 254 0.5× 118 0.3× 79 0.3× 88 0.5× 191 2.4k
Wenwen Huang China 27 1.2k 1.2× 329 0.6× 456 1.2× 326 1.1× 155 1.0× 107 2.5k
Linghua Meng China 30 1.7k 1.6× 623 1.2× 274 0.7× 228 0.8× 195 1.2× 109 2.9k

Countries citing papers authored by Lina Yang

Since Specialization
Citations

This map shows the geographic impact of Lina Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lina Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lina Yang more than expected).

Fields of papers citing papers by Lina Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lina Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lina Yang. The network helps show where Lina Yang may publish in the future.

Co-authorship network of co-authors of Lina Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Lina Yang. A scholar is included among the top collaborators of Lina Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lina Yang. Lina Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Wenbo, et al.. (2025). SHMT proteins: An emerging set of serine hydroxymethyltransferase in cancer. Cellular Signalling. 135. 111977–111977. 1 indexed citations
2.
Li, Qianwen, Fansu Meng, Lina Yang, et al.. (2025). Metabolic Reprogramming of Tumors: Induced Immunosuppression and Therapeutic Prospects of Nanoscale Drug Delivery Systems. Molecular Pharmaceutics. 22(9). 5193–5211.
3.
Ding, Xiaoyan, et al.. (2024). UBA3 promotes the occurrence and metastasis of intrahepatic cholangiocarcinoma through MAPK signaling pathway. Acta Biochimica et Biophysica Sinica. 56(2). 199–209. 9 indexed citations
5.
Dong, Xiaolei, Guoxiang Liu, Mengjun Wang, et al.. (2024). METTL protein family: focusing on the occurrence, progression and treatment of cancer. Biomarker Research. 12(1). 105–105. 8 indexed citations
6.
Chen, Guang, Xiaoyan Ding, Guoxiang Liu, et al.. (2023). Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K/AKT/mTOR signal pathway. APOPTOSIS. 28(9-10). 1390–1405. 29 indexed citations
7.
Hill, LaQuisa, Rayne H. Rouce, Meng-Fen Wu, et al.. (2023). Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas. Blood. 143(13). 1231–1241. 30 indexed citations
8.
Yang, Lina, et al.. (2022). Wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer. Journal of Ovarian Research. 15(1). 56–56. 3 indexed citations
9.
Rouce, Rayne H., LaQuisa Hill, Tyler S. Smith, et al.. (2021). Early Signals of Anti-Tumor Efficacy and Safety with Autologous CD5.CAR T-Cells in Patients with Refractory/Relapsed T-Cell Lymphoma. Blood. 138(Supplement 1). 654–654. 14 indexed citations
10.
Wang, Fengjiao, Chao Qu, Lianyu Chen, et al.. (2021). Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling. BMC Cancer. 21(1). 396–396. 114 indexed citations
11.
Yang, Lina, et al.. (2020). Exploring Mechanism of Key Chinese Herbal Medicine on Breast Cancer by Data Mining and Network Pharmacology Methods. Chinese Journal of Integrative Medicine. 27(12). 919–926. 19 indexed citations
12.
Hill, LaQuisa, Rayne H. Rouce, Tyler S. Smith, et al.. (2019). Safety and Anti-Tumor Activity of CD5 CAR T-Cells in Patients with Relapsed/Refractory T-Cell Malignancies. Blood. 134(Supplement_1). 199–199. 51 indexed citations
13.
Qiang, Hao, et al.. (2019). Design of permanent magnet synchronous motor servo controller based on bandwidth. 43(6). 677–683. 1 indexed citations
14.
Wang, Xuanyu, Lina Yang, Xiaoyu Tan, et al.. (2019). HPD overexpression predicts poor prognosis in breast cancer. Pathology - Research and Practice. 215(9). 152524–152524. 9 indexed citations
16.
Yang, Yuqi, Sheng Yin, Shuqing Li, Yaping Chen, & Lina Yang. (2019). <p>Stanniocalcin 1 in tumor microenvironment promotes metastasis of ovarian cancer</p>. OncoTargets and Therapy. Volume 12. 2789–2798. 19 indexed citations
17.
Han, Xu, Fengjuan Lin, Ziliang Wang, et al.. (2017). CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2. Cancer Letters. 412. 69–80. 86 indexed citations
18.
Mathison, Megumi, Vivek Singh, Deepthi Sanagasetti, et al.. (2017). Cardiac reprogramming factor Gata4 reduces postinfarct cardiac fibrosis through direct repression of the profibrotic mediator snail. Journal of Thoracic and Cardiovascular Surgery. 154(5). 1601–1610.e3. 19 indexed citations
19.
Li, Rongying, Jeongkyung Lee, Mi Sun Kim, et al.. (2014). PD-L1–Driven Tolerance Protects Neurogenin3-Induced Islet Neogenesis to Reverse Established Type 1 Diabetes in NOD Mice. Diabetes. 64(2). 529–540. 20 indexed citations
20.
Zhou, Donghui, Lina Yang, Christian Röder, Holger Kalthoff, & Anna Trauzold. (2013). TRAIL-induced expression of uPA and IL-8 strongly enhanced by overexpression of TRAF2 and Bcl-xL in pancreatic ductal adenocarcinoma cells. Hepatobiliary & pancreatic diseases international. 12(1). 94–98. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026